http://finance.yahoo.com/news/EU-clears-JJ-and-DexCom-apf-2889549504.html?x=0
The device combines the Animas insulin pump, which was developed by a Johnson & Johnson unit, with continuous blood glucose monitoring technology from DexCom Inc. It measures glucose levels in interstitial fluid, which is liquid similar to blood plasma that bathes tissues and is exchanged with plasma through pores in capillary walls.
The device combines the Animas insulin pump, which was developed by a Johnson & Johnson unit, with continuous blood glucose monitoring technology from DexCom Inc. It measures glucose levels in interstitial fluid, which is liquid similar to blood plasma that bathes tissues and is exchanged with plasma through pores in capillary walls.
